Private company

Xellia

Pharmaceutical company in Denmark

Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen specialized in the production of anti-biotics, including Vancomycin and Bacitracin. The company's US base of operations is in Buffalo Grove, Illinois, with additional facilities in Ohio, and North Carolina.2 It is part of Novo Holdings.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 20, 2026.

Overview

2008Founded1
  • Industrypharmaceutical industry1
  • HeadquartersCopenhagen1
  • Websitexellia.com
  • Legal formanpartsselskab1
  • LEI549300QZH7QG20ETC1563
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressDalslandsgade 11, 2300 København S, Denmark3
  • Registered withDanish Business Authority, 610946283

Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen specialized in the production of anti-biotics, including Vancomycin and Bacitracin. The company's US base of operations is in Buffalo Grove, Illinois, with additional facilities in Ohio, and North Carolina.2

Corporate structure

Xellia is part of a group headed by Novo Nordisk Foundation. 32 entities, 11 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Novo Nordisk Foundation Hellerup, Denmark
    • Novo Holdings 100% · Hellerup, Denmark
      • Catalent Pharma Solutions Subsidiary · Bridgewater, New Jersey, United States
      • Dades Subsidiary · Kongens Lyngby, Denmark
      • NNIT Subsidiary · København S, Denmark
      • Novo Ventures Subsidiary · Hellerup, Denmark
      • NH AIFM P/S Subsidiary · Hellerup, Denmark
        • NH PE FII SCSp Fund · Hellerup, Denmark
        • NH PE FIII SCSp Fund · Hellerup, Denmark
      • NH GP PE FII S.a r.l. (NH GP PE FII S.à r.l.) Subsidiary · Howald, Luxembourg
      • NH GP PE FIII S.a r.l. (NH GP PE FIII S.à r.l.) Subsidiary · Howald, Luxembourg
    • Xellia København S, Denmark
    • Novo Stake · 28.1% · Bagsværd, Denmark
      • NNE A/S Virum, Denmark
      • Novo Nordisk (Algeria) Subsidiary · Hydra, Algeria
      • Novo Nordisk (Germany) Subsidiary · Mainz, Germany
      • Novo Nordisk (United States) Subsidiary · Seattle, United States
      • Novo Nordisk s.r.o. Subsidiary · Prague, Czech Republic
      • Novo Nordisk (Switzerland) Subsidiary · Switzerland
      • NOVO NORDISK FINANCE (NETHERLANDS) B.V. Subsidiary · Bagsvaerd, Denmark
      • NOVO NORDISK HEALTH CARE AG Subsidiary · Zurich, Switzerland
      • NOVO NORDISK REGION EUROPE A/S Subsidiary · Bagsværd, Denmark
      • NOVO NORDISK SERVICE CENTRE (INDIA) PRIVATE LIMITED Subsidiary · Bangalore, India
    • Novonesis Stake · 23.87% · Bagsvaerd, Denmark
      • Novozymes (Canada) Subsidiary · Ottawa, Canada
      • Novozymes (United States) Subsidiary · Franklinton, United States
      • CHR. HANSEN A/S Subsidiary · Hørsholm, Denmark
      • Novozymes Japan Ltd. (Japan) Subsidiary · Japan
      • Precisionbiotics Group Limited Subsidiary · Cork, Ireland
    • NEW XELLIA GROUP A/S Subsidiary · København S, Denmark
    • NH GP PE FI S.a r.l. (NH GP PE FI S.à r.l.) Subsidiary · Luxembourg, Luxembourg
    • NH PE FI SCSp Fund · Hellerup, Denmark

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

Ultimate parent

From Wikidata.1 Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Timeline

  1. 2008Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3